No Data
No Data
Curis Price Target Maintained With a $26.00/Share by Truist Securities
Curis Price Target Maintained With a $26.00/Share by Truist Securities
Curis Is Maintained at Buy by Truist Securities
Curis Is Maintained at Buy by Truist Securities
Express News | Cantor Fitzgerald Reiterates Overweight on Curis
Express News | Curis Inc : Jonestrading Cuts Target Price to $18 From $27
Analysts Have Conflicting Sentiments on These Healthcare Companies: Curis (CRIS), Health Catalyst (HCAT) and Innate Pharma SA (OtherIPHYF)
Curis Inc Showcases Leukemia Study Breakthroughs at Conferences
No Data